TriLyte Interactions
There are 392 drugs known to interact with TriLyte (polyethylene glycol 3350 with electrolytes), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 35 are major, 356 are moderate, and 1 is minor.
- View all 392 medications that may interact with TriLyte
- View TriLyte alcohol/food interactions (1)
- View TriLyte disease interactions (7)
Most frequently checked interactions
View interaction reports for TriLyte (polyethylene glycol 3350 with electrolytes) and the medicines listed below.
- acetaminophen / hydrocodone
- Advair Diskus (fluticasone / salmeterol)
- albuterol
- Align (bifidobacterium infantis)
- amlodipine
- Asacol (mesalamine)
- Augmentin (amoxicillin / clavulanate)
- Benadryl (diphenhydramine)
- calcium citrate
- Claritin (loratadine)
- doxycycline
- escitalopram
- famotidine
- gabapentin
- hydrochlorothiazide
- lidocaine
- lisinopril
- lorazepam
- losartan
- mesalamine
- metoprolol
- metronidazole
- MiraLAX (polyethylene glycol 3350)
- Nexium (esomeprazole)
- nortriptyline
- omeprazole
- pantoprazole
- prednisone
- promethazine
- rosuvastatin
TriLyte alcohol/food interactions
There is 1 alcohol/food interaction with TriLyte (polyethylene glycol 3350 with electrolytes).
TriLyte disease interactions
There are 7 disease interactions with TriLyte (polyethylene glycol 3350 with electrolytes) which include:
- inflammatory bowel disease
- intestinal obstruction disorders
- GI obstruction/perforation
- arrhythmias
- impaired gag reflex
- renal disease
- seizures
Report options
More about TriLyte (polyethylene glycol 3350 with electrolytes)
- TriLyte consumer information
- Compare alternatives
- Reviews (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: laxatives
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.